Home Financial Results

Financial Results

APL Apollo Quarterly Results.

APL Apollo Quarterly Results.

New Delhi, August 17, 2019: APL Apollo Tubes Limited (APL Apollo), India’s leading branded steel tubes manufacturer, marked a strong start to the new fiscal year 2020. The sales volume, excluding Coil & Scrap, posted a robust growth of...
Poly Medicure Limited (POLYMED) PAT Jumps 48% to Rs. 20.18 Crores in Q1 FY20

Poly Medicure Limited (POLYMED) PAT Jumps 48% to Rs. 20.18 Crores in Q1 FY20

New Delhi, August 15, 2019: Poly Medicure Limited announced Financial Results for its Q1 FY 19-20 ended June 30, 2019. The company has reported a 15.74% increase in total income at Rs. 156.53 crores during the period ended June...
TAKE Solutions announces Q1 FY20 results, reports 24.6% Y-o-Y growth

TAKE Solutions announces Q1 FY20 results, reports 24.6% Y-o-Y growth

Revenue up 24.6% Y-o-Y to INR 5,827.4 Mn, Operating EBITDA at INR 1,095.5 Mn  Chennai, August 10, 2019: TAKE Solutions Ltd. , a globally recognized domain intensive services provider in Life Sciences, today announced its Q1 FY20 financial results. The...
Clariant Chemicals Q1 profits up by 20.3%; Sales grew by 11.9%

Clariant Chemicals Q1 profits up by 20.3%; Sales grew by 11.9%

Mumbai, August 09, 2019: Clariant Chemicals (India) Limited reported profit before tax of Rs. 18.4 crore for the quarter ended June 2019, as compared to profit before tax of Rs. 15.3 crore for the quarter ended June 2018 –...

Dr. Reddy’s Q1 FY20 Financial Results

Hyderabad, July 29, 2019: Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter ended June 30, 2019 under International Financial Reporting Standards (IFRS). Commenting on the results, CEO...

Jubilant Life Sciences – Q1’FY20 Results

  Revenue at Rs. 2,182 Crore up 5% YoY; EBITDA at Rs 444 Crores down 1% YoY PAT at Rs 185 Crore down 9% YoY with EPS of Rs. 11.6 per share vs Rs 13.0 per share last year New Delhi,...

Piramal’s Pharma business grows over 10 % to 4,786 Crore in FY19

 The margins have improved from 10% in FY2011 to 23% in FY2019 Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing Operations (CDMO) Mumbai, July : Over 90% of Piramal's Pharma revenues derived...

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775 Crore Normalised PAT at Rs. 855 Crore with EPS at Rs. 54 per share Q4'FY19 Revenue at Rs 2,386...

Caredose registers 425% growth in the last quarter of FY 2018-19

To expand its services to five more cities apart from Delhi-NCR Targets expansion in South East Asia, Africa and Middle East by next year New Delhi, April 10, 2019: A MedTech start-up company, Caredose, announced today that it has...